Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Epilepsy

methylprednisolone hemisuccinate has been researched along with Epilepsy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gold, R; Hoepner, R; Krogias, C; Müller, A; Schneider-Gold, C; Schröder, A1
Blanc, T; Devaux, AM; Ensel, P; Monroc-Morval, M; Paillard, C; Vanhulle, C1

Other Studies

2 other study(ies) available for methylprednisolone hemisuccinate and Epilepsy

ArticleYear
Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab.
    JAMA neurology, 2013, Volume: 70, Issue:8

    Topics: Antibodies, Monoclonal, Humanized; Chorea; Combined Modality Therapy; Dysarthria; Dystonia; Epilepsy; Follow-Up Studies; Humans; Male; Membrane Proteins; Methylprednisolone Hemisuccinate; Middle Aged; Nerve Tissue Proteins; Receptors, Interleukin-6; Remission Induction; Syndrome; Treatment Outcome

2013
[Recurrence of herpes simplex encephalitis].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:10

    Topics: Acyclovir; Anti-Anxiety Agents; Anti-Inflammatory Agents; Anticonvulsants; Antiviral Agents; Benzodiazepines; Brain; Child, Preschool; Clobazam; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Epilepsy; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Methylprednisolone Hemisuccinate; Recurrence; Time Factors; Tomography, X-Ray Computed; Valproic Acid; Vigabatrin

1999
chemdatabank.com